You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Osteonecrosis of the jaw in a Crohn’s disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report
|
---|---|
Published in |
BMC Gastroenterology, January 2014
|
DOI | 10.1186/1471-230x-14-6 |
Pubmed ID | |
Authors |
Raimund HM Preidl, Tobias Ebker, Martin Raithel, Falk Wehrhan, Friedrich W Neukam, Philipp Stockmann |
Abstract |
Bisphosphonates have a widespread indication for osteoporosis and are also applied in cancer patients with skeletal-related conditions. Bisphosphonate-associated osteonecrosis of the jaw (BRONJ) is a feared side effect which is hard to treat and often affects patient's quality of life in an extensive manner. Adalimumab (Humira®), a fully human recombinant antibody specific for tumor necrosis factor- α, is approved for treatment in patients with Inflammatory Bowel Disease like ulcerative colitis or Crohn's disease. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | <1% |
Unknown | 100 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 13 | 13% |
Student > Master | 13 | 13% |
Other | 12 | 12% |
Researcher | 10 | 10% |
Student > Bachelor | 7 | 7% |
Other | 21 | 21% |
Unknown | 25 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 56 | 55% |
Agricultural and Biological Sciences | 5 | 5% |
Psychology | 3 | 3% |
Nursing and Health Professions | 3 | 3% |
Arts and Humanities | 1 | <1% |
Other | 7 | 7% |
Unknown | 26 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2014.
All research outputs
#20,216,580
of 22,739,983 outputs
Outputs from BMC Gastroenterology
#1,359
of 1,737 outputs
Outputs of similar age
#264,248
of 304,743 outputs
Outputs of similar age from BMC Gastroenterology
#25
of 26 outputs
Altmetric has tracked 22,739,983 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,737 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 304,743 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.